Actavis Recalls Glipizide 2.5 mg Extended-Release Tablets for Dissolution Failure
Actavis Inc is recalling specific lots of Glipizide 2.5 mg Extended-Release tablets because they failed to meet dissolution specifications.
- Product
- Glipizide 2.5 mg Extended-release tablets, 30-count bottle, Rx Only, Manufactured By: Patheon Pharmaceuticals Inc Cincinnati, OH 45237, NDC 00591-0900-30
- Category
- Drug
- Distribution
- Distributed nationwide